Committee on
Safety of Medicines debates Vioxx CV
risks based on MHRA 2001 report
This material is from a
2005 investigation by Brian Deer for The Sunday
Times of London into the painkiller Vioxx
| Go to Vioxx index
The document below is a
restricted report, titled
"The cardiovascular safety of
rofecoxib (and other selective COX-2
inhibitors)", by the UK
Medicines and Healthcare products
Regulatory Agency submitted to a meeting
of the British government's Committee on
Safety of Medicines held on December 12
2001
Notes:
Redactions to this document are by the UK
Medicines and Healthcare products
Regulatory Agency on supply to Brian Deer
under freedom of information law. Annexes
may be available by emailing Brian
Deer, but supply isn't
guaranteed. Please support investigative
journalism by linking to this page and/or
crediting this website:
briandeer.com
|